December 11, 2013
The budget deal moves the needle in the right direction but not far enough. We’re gratified medical research and other non-defense discretionary programs will get a modicum of relief from sequestration’s bitter pill but it’s not enough to meet the expectations of patients waiting for new treatments and cures. The budget deal also fails to address tax and entitlement reform, the main contributors to our deficit. Until policy makers tackle those issues head-on, we will continue to fund medical innovation at levels far below what’s necessary to maintain our competitive edge.